Wanted: More Women to Become Financial Planners
Fill'er Up With Weird: Our Readers' Surprising Gas Saving Tips
Amazon to Turn Fan Fiction into a Money Maker with Kindle Worlds
Midday Market Minute: Are Beer Sales Tapped Out for 2013?
PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More
Wider-Than-Expected Loss at Athersys - Analyst Blog
Athersys Management Discusses Q1 2013 Results - Earnings Call Transcript
Athersys reports Q1 EPS (18c), consensus (11c)
Athersys Reports First Quarter 2013 Results
Does Cell Therapy Hold The Key To Treating Stroke?
Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance
Athersys Has Some Promise, But Controversy And Doubt Remain
Athersys to Present at 12th Annual Needham Healthcare Conference